Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In the interest of full disclosure.
Burkard ME, Tevaarwerk AJ, Wisinski KB. Burkard ME, et al. Among authors: wisinski kb. Lancet Oncol. 2010 Apr;11(4):314-5; author reply 315. doi: 10.1016/S1470-2045(10)70044-9. Lancet Oncol. 2010. PMID: 20359661 No abstract available.
Adjuvant therapy for HER2+ breast cancer: practice, perception, and toxicity.
Rocque G, Onitilo A, Engel J, Pettke E, Boshoven A, Kim K, Rishi S, Waack B, Wisinski KB, Tevaarwerk A, Burkard ME. Rocque G, et al. Among authors: wisinski kb. Breast Cancer Res Treat. 2012 Jan;131(2):713-21. doi: 10.1007/s10549-011-1862-y. Epub 2011 Nov 8. Breast Cancer Res Treat. 2012. PMID: 22065290 Free PMC article.
Aromatase inhibitors and calcium absorption in early stage breast cancer.
Tevaarwerk A, Burkard ME, Wisinski KB, Shafer MM, Davis LA, Gogineni J, Crone E, Hansen KE. Tevaarwerk A, et al. Among authors: wisinski kb. Breast Cancer Res Treat. 2012 Jul;134(1):245-51. doi: 10.1007/s10549-012-1982-z. Epub 2012 Feb 18. Breast Cancer Res Treat. 2012. PMID: 22350731 Free PMC article. Clinical Trial.
Feasibility of 4 cycles of docetaxel and cyclophosphamide every 14 days as an adjuvant regimen for breast cancer: a Wisconsin Oncology Network study.
Burkard ME, Wisinski KB, Njiaju UO, Donohue S, Hegeman R, Stella A, Mansky P, Shah V, Goggins T, Qamar R, Dietrich L, Kim K, Traynor AM, Tevaarwerk AJ. Burkard ME, et al. Among authors: wisinski kb. Clin Breast Cancer. 2014 Jun;14(3):205-11. doi: 10.1016/j.clbc.2013.10.018. Epub 2013 Oct 26. Clin Breast Cancer. 2014. PMID: 24342730 Free PMC article. Clinical Trial.
Development and evaluation of a survey to assess survivor knowledge change after survivorship care plans: WiSDOM-B (Wisconsin Survey of cancer DiagnOsis and Management in Breast cancer).
Rocque GB, Wisinski KB, Buhr KA, Froeschner JL, Jones N, Donohue S, Wiegmann D, Sesto ME, Tevaarwerk AJ. Rocque GB, et al. Among authors: wisinski kb. J Cancer Educ. 2014 Jun;29(2):270-7. doi: 10.1007/s13187-013-0591-9. J Cancer Educ. 2014. PMID: 24343267 Free PMC article. Clinical Trial.
Treatment differences between urban and rural women with hormone receptor-positive early-stage breast cancer based on 21-gene assay recurrence score result.
Andreason M, Zhang C, Onitilo AA, Engel J, Ledesma WM, Ridolfi K, Kim K, Charlson JC, Wisinski KB, Tevaarwerk AJ. Andreason M, et al. Among authors: wisinski kb. J Community Support Oncol. 2015 May;13(5):195-201. doi: 10.12788/jcso.0135. J Community Support Oncol. 2015. PMID: 26029936 Free PMC article.
77 results